The gene coding for the protein p53 is probably the most important factor in protecting human cells from cancer caused by DNA-damaging agents. The protein allows cells to repair damage to their DNA and thereby prevents the development of cancers, which is why it has been nicknamed “the guardian of the genome”.
An inactivation of p53 can be found in about one in two tumors. Cells lacking p53 function become genomically instable, which implies that they are prone to acquire mutations in their DNA, helping the tumors to grow in uncontrolled ways, form metastases, and resist therapy. Hence, the cancer cell becomes more aggressive.
But even when there are no DNA-damaging agents around, it is an extremely difficult task for cells to maintain their genomic (DNA) stability. Researchers have suspected that p53's protective function also covers healthy cells. The mechanism by which the protein would gain such capabilities, however, has remained unclear. A research team has now shed new light on this mystery.
Cells – and their DNA integrity – are particularly at risk when they divide, as they duplicate their DNA in the process. “Like in any other replication process, such as photocopying a document or copying a digital file, it is disastrous if the template moves or is changed while the copy is being made. For this reason, genes cannot be transcribed – i.e. used as templates for proteins – while the DNA is being copied,” the author explains. If they are transcribed anyway, serious disruptions occur, which can lead to cancer-promoting mutations. The results from the team, now appearing as the cover story in Cell Reports, show that p53 inactivation favors such copy-related damage. They found that p53 normally acts by changing cell metabolism in a way that prevents activation of genome regions that should remain inactive.
The scientists painstakingly dissected the underlying mechanism down to the last detail. They made use of the knowledge that some parts of the genome, called heterochromatin, are packed densely to prevent transcription of genes in these regions. For this reason, such regions are called “silent”, and they are controlled by what is known as epigenetic mechanisms, i.e. processes that do not affect the genes as such, but their overall packaging and accessibility in the genome. One of the most interesting findings of the recent study was that in the absence of p53 these usually inaccessible or “silent” regions of our DNA were transcribed, leading to catastrophic consequences.
“Normally, transcription of these areas of the genome should be kept under tight control, and p53 is the key to keeping their information locked-away by controlling metabolism in a way that renders the heterochromatin inaccessible,” the author says. When p53 is absent, as in p53-inactivated tumors, the cell loses its metabolic homeostasis, and the information hidden in the heterochromatin becomes aberrantly accessible and is transcribed. This causes so much damage that it will drive cells into a state of genomic instability that favors and worsens cancer progression.
“By unravelling this mechanism, we could demonstrate that there is a link between metabolism, epigenetic integrity and genomic stability. In addition, we provided evidence that p53 represents the switch controlling the on/off status of this protection system in the response to environmental stress,” the author summarizes the finding.
The question of how p53-inactivated tumors develop genomic instability has plagued the scientific community for quite some time. “Now we have certainty that, in these tumors, there is a problem at the metabolic level that is reflected in the integrity of the epigenome. Hence, p53 should actually be called guardian of the (epi-)genome. This essential insight can direct research to identify potential new therapeutic strategies for the very frequent forms of cancers that carry p53 inactivation,” the author concludes.
https://www.cell.com/cell-reports/fulltext/S2211-1247(22)01429-2
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fmetabolic-regulation-by&filter=22
How p53-inactivated tumors develop genomic instability
- 583 views
- Added
Latest News
Propionic acid protects ner…
By newseditor
Posted 28 Jan
How cells prevent harmful e…
By newseditor
Posted 28 Jan
Structured cerebellar conne…
By newseditor
Posted 28 Jan
Origins of pleasurable touc…
By newseditor
Posted 25 Jan
Unknown way cells protect t…
By newseditor
Posted 25 Jan
Other Top Stories
Mating can cause epigenetic changes that last for 300 generations
Read more
Gene therapy to treat developmental disabilities
Read more
Neurotransmitter release impairment in schizophrenia with genetic m…
Read more
Prenatal editing in preclinical model to correct lysosomal storage…
Read more
Potential role of 'junk DNA' sequence in aging, cancer
Read more
Protocols
Machine learning prediction…
By newseditor
Posted 09 Jan
Differentiating PC12 cells…
By newseditor
Posted 09 Jan
Ultrasensitive sensors reve…
By newseditor
Posted 05 Jan
In vitro-derived medium spi…
By newseditor
Posted 04 Jan
Molecular and spatial signa…
By newseditor
Posted 30 Dec
Publications
Brainstem networks construc…
By newseditor
Posted 28 Jan
The role of platelets in im…
By newseditor
Posted 28 Jan
Invariant inhibition to cal…
By newseditor
Posted 27 Jan
Birdsong neuroscience and t…
By newseditor
Posted 27 Jan
Touch neurons underlying do…
By newseditor
Posted 25 Jan
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 10 Mar
ASCO-2020-GYNECOLOGIC CANCER
By newseditor
Posted 10 Mar